Fate Therapeutics, Inc. (FATE) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Fate Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.089 -- 00:00:05.172 Welcome to the FATE Therapeutics Third Quarter 2023 Financial Results Conference Call. 00:00:05.172 -- 00:00:08.293 At this time, all participants are in a listen-only mode. 00:00:08.293 -- 00:00:14.055 The call is being webcast live on the Investors section of FATE's website at fatetherapeutics.com. 00:00:14.277 -- 00:00:16.938 As a reminder, today's call is being recorded. 00:00:16.938 -- 00:00:19.980 I would now like to introduce Scott Wolko, 00:00:19.980 -- 00:00:23.440 President and CEO of FATE Therapeutics. 00:00:24.082 -- 00:00:29.191 Thank you. Good afternoon and thanks everyone for joining us for the FAPE Therapeutics 00:00:29.191 -- 00:00:31.312 third quarter 2023 00:00:31.312 -- 00:00:34.873 financial results call. Shortly after 4 p.m. 00:00:34.873 -- 00:00:40.214 Eastern time today, we issued a press release with these results, which can be found 00:00:40.214 -- 00:00:44.816 on the investor section of our website under press releases. 00:00:44.816 -- 00:00:49.897 In addition, our form 10-Q for the quarter ended September 30, 2023 was filed 00:00:49.897 -- 00:00:52.257 shortly thereafter 00:00:53.382 -- 00:00:59.203 and can be found on the Investors section of our website under Financial Information. 00:00:59.203 -- 00:01:03.425 Before we begin, I would like to remind everyone that except for statements of historical 00:01:03.425 -- 00:01:08.866 facts, the statements made by management and responses to questions on this conference 00:01:08.866 -- 00:01:14.207 call are forward-looking statements under the safe harbor provisions of the Private 00:01:14.207 -- 00:01:18.668 Securities Litigation Reform Act of 1995. These 00:01:18.808 -- 00:01:25.037 statements involve risks and uncertainties that can cause actual results to ...